Non-coding RNAs and neuroinflammation: implications for neurological disorders
Authors:
Open Access
- 28 February 2024
- journal article
- review article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 249, 10120
Abstract
Neuroinflammation is considered a balanced inflammatory response important in the intrinsic repair process after injury or infection. Under chronic states of disease, injury, or infection, persistent neuroinflammation results in a heightened presence of cytokines, chemokines, and reactive oxygen species that result in tissue damage. In the CNS, the surrounding microglia normally contain macrophages and other innate immune cells that perform active immune surveillance. The resulting cytokines produced by these macrophages affect the growth, development, and responsiveness of the microglia present in both white and gray matter regions of the CNS. Controlling the levels of these cytokines ultimately improves neurocognitive function and results in the repair of lesions associated with neurologic disease. MicroRNAs (miRNAs) are master regulators of the genome and subsequently control the activity of inflammatory responses crucial in sustaining a robust and acute immunological response towards an acute infection while dampening pathways that result in heightened levels of cytokines and chemokines associated with chronic neuroinflammation. Numerous reports have directly implicated miRNAs in controlling the abundance and activity of interleukins, TGF-B, NF-kB, and toll-like receptor-signaling intrinsically linked with the development of neurological disorders such as Parkinson’s, ALS, epilepsy, Alzheimer’s, and neuromuscular degeneration. This review is focused on discussing the role miRNAs play in regulating or initiating these chronic neurological states, many of which maintain the level and/or activity of neuron-specific secondary messengers. Dysregulated miRNAs present in the microglia, astrocytes, oligodendrocytes, and epididymal cells, contribute to an overall glial-specific inflammatory niche that impacts the activity of neuronal conductivity, signaling action potentials, neurotransmitter robustness, neuron-neuron specific communication, and neuron-muscular connections. Understanding which miRNAs regulate microglial activation is a crucial step forward in developing non-coding RNA-based therapeutics to treat and potentially correct the behavioral and cognitive deficits typically found in patients suffering from chronic neuroinflammation.Keywords
This publication has 207 references indexed in Scilit:
- The “guiding” principles of noncoding RNA functionWIREs RNA, 2021
- Neuroinflammation in Parkinson's disease: a meta-analysis of PET imaging studiesJournal of Neurology, 2021
- Toll‐like receptors in neuroinflammation, neurodegeneration, and alcohol‐induced brain damageIUBMB Life, 2021
- The pro‐inflammatory microRNA miR‐155 influences fibrillar β‐Amyloid1‐42 catabolism by microgliaGlia, 2021
- Brief history of anti‐seizure drug developmentEpilepsia Open, 2018
- Noncoding RNA in NK cellsJournal of Leukocyte Biology, 2018
- Regulation of primary microRNA processingFEBS Letters, 2018
- Reciprocal Regulation of MicroRNA-122 and c-Myc in Hepatocellular Cancer: Role of E2F1 and Transcription Factor Dimerization Partner 2Hepatology, 2013
- Synthesis of RNA by In Vitro Transcription2010
- Non‐coding RNAs: regulators of diseaseThe Journal of Pathology, 2009